Israel’s Rosetta Genomics has received a US patent for its microRNA-based test for the primary tumor type in primary and metastatic (secondary) cancer. By identifying the origin of the tumor, physicians can select the best treatment options for the patient. … Continue reading →

In a study of 484 people (99 with stomach cancer), Israel’s NaNose breath detector gave an 80% accurate diagnosis – matching far more expensive, slower and invasive alternatives. NaNose (developed by Technion’s Dr Hossam Haick) also detected pre-cancerous growths that … Continue reading →

Israel Technion’s Nobel laureate Aaron Ciechanover is in the news for the second week in a row. His recent findings form the basis of a joint project to develop cancer treatments with India’s Sun Pharma. http://www.business-standard.com/article/pti-stories/sun-pharma-israel-univ-ink-pact-to-develop-anti-cancer-drugs-115041500844_1.html

I featured the amazing work of Tel Aviv University’s Professor Dan Peer in my 8 Mar 2015 newsletter. But I thought that you’d like to hear the story from the Professor direct. https://www.youtube.com/watch?v=LdNXns6xAfQ http://www.timesofisrael.com/nano-bullet-tech-shoots-down-brain-cancer-in-tel-aviv-u-study/

Israel’s Kamada has been allowed a patent in Canada for the large-scale production of Alpha-1 Proteinase Inhibitor. The process is key to Kamada’s treatments for alpha-1 antitrypsin (AAT) deficient patients suffering from type-1 diabetes and pulmonary diseases, amongst others. http://www.globes.co.il/en/article-kamada-receives-canadian-patent-1001025127

Medical researchers at Hadassah Medical School in Jerusalem studying the effects of liver transplants in mice, found that in 96% of older, pregnant rodents, the liver regenerated within two days. This compared with 82% of young, non-pregnant mice and 46% … Continue reading →

Israel’s Timocco makes motor skills games for developmentally disabled and autistic children. It is now locating its US HQ in Akron Ohio and is working with Akron Children’s Hospital, Cleveland Clinic and University Hospitals to introduce the software. http://www.cleveland.com/akron/index.ssf/2015/03/israeli_software_company_to_op.html

Israel’s Ninox Medical has raised $10 million to fund its development of a new device for the treatment of Obstructive Sleep Apnea (OSA). It is designed to be effective, comfortable to use, and without the side effects typical of other … Continue reading →